Table 2.
CASC (N = 285) | Control (N = 287) | P- valuea | |
---|---|---|---|
Change from weeks 0 to 24 | |||
MPSS urge total | −1.87 [−2.01 to −1.72] | −1.73 [−1.88 to −1.59] | 0.009 |
MPSS total excluding urges | −0.59 [−0.72 to −0.47] | −0.42 [−0.56 to −0.29] | <0.001 |
FTCQ-12 emotionality | −1.70 [−1.89 to −1.51] | −1.32 [−1.49 to −1.14] | <0.001 |
FTCQ-12 expectancy | −2.46 [−2.68 to −2.25] | −2.16 [−2.37 to −1.95] | 0.002 |
FTCQ-12 compulsivity | −1.74 [−1.94 to −1.54] | −1.74 [−1.93 to −1.55] | 0.202 |
FTCQ-12 purposefulness | −2.84 [−3.10 to −2.58] | −2.17 [−2.44 to −1.90] | <0.001 |
FTCQ-12 general craving score | −2.09 [−2.25 to −1.93] | −1.78 [−1.93 to −1.63] | <0.001 |
KTSND | −7.0 [−7.7 to −6.2] | −3.9 [−4.5 to −3.2] | <0.001 |
Change from weeks 0 to 52 | |||
MPSS urge total | −1.82 [−1.98 to −1.67] | −1.65 [−1.81 to −1.49] | 0.007 |
MPSS total excluding urges | −0.52 [−0.64 to −0.39] | −0.42 [−0.54 to −0.29] | 0.061 |
FTCQ-12 emotionality | −1.60 [−1.80 to −1.41] | −1.21 [−1.39 to −1.03] | 0.001 |
FTCQ-12 expectancy | −2.39 [−2.60 to −2.19] | −2·10 [−2.33 to −1.88] | 0.002 |
FTCQ-12 compulsivity | −1.71 [−1.90 to −1.52] | −1.55 [−1.75 to −1.35] | 0.019 |
FTCQ-12 purposefulness | −2.84 [−3.10 to −2.58] | −2.00 [−2.28 to −1.73] | <0.001 |
FTCQ-12 general craving score | −2.03 [−2.19 to −1.87] | −1.65 [−1.81 to −1.48] | <0.001 |
KTSND | −5.9 [−6.6 to −5.3] | −4.1 [−4.8 to −3.5] | <0.001 |
Mean [95% CI] scores are provided. Covariates: medications (varenicline, nicotine patch, or none) and medical institutions.
MPSS Mood and Physical Symptoms Scale (ranging from 0 to 5), FTCQ-12 French version of the Tobacco Craving Questionnaire 12 (ranging from 1 to 7), KTSND Kano Test for Social Nicotine Dependence (ranging from 0 to 30), CI confidence interval.
aAnalysis was based on analysis of covariance.